Skip to main content
Livermore
Livermore
ZHEN

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Tarsus Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of TARS: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders2466253+13
Shares44.1M2.52M45.1M+3.61M (+8.7%)
Value$3.61B$206.6M$3.17B−$232.9M (−6.9%)

6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to TARS in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC1,760,541$123.5M0.00%
Vanguard Portfolio Management LLC335,889$23.6M0.00%
Vanguard Fiduciary Trust Co272,743$19.1M0.00%
Braidwell LP265,715$18.6M0.62%
Tri Locum Partners LP252,588$17.7M2.49%
Vestal Point Capital, LP200,000$14.0M0.39%
M&G Plc166,364$11.6M0.06%
Citadel Advisors LLC163,997$11.5M0.01%
Ally Bridge Group (NY) LLC80,859$5.67M5.64%
Emerald Investment Advisers, LLC39,896$2.80M0.25%
Caption Management, LLC36,448$2.56M0.12%
Nomura Holdings Inc34,685$2.43M0.02%
EFG International AG34,133$2.40M0.05%
Diadema Partners LP25,942$1.82M0.75%
Lido Advisors, LLC24,374$1.71M0.01%
Man Group plc23,252$1.63M0.00%
Vanguard Asset Management, Ltd20,748$1.46M0.00%
Wedge Capital Management L L P19,704$1.38M0.03%
Vanguard Global Advisers, LLC16,427$1.15M0.00%
Zacks Investment Management14,879$1.04M0.01%
VARCOV Co.14,875$1.04M0.39%
CIBC World Markets Inc.12,500$876.9K0.00%
HSBC Holdings PLC9,643$686.1K0.00%
Martingale Asset Management L P9,100$638.4K0.02%
Aquatic Capital Management LLC8,985$630.3K0.02%
Vanguard Investments Australia, Ltd.7,549$529.6K0.00%
Persistent Asset Partners Ltd6,556$459.9K0.18%
Verdad Advisers, LP6,328$443.9K0.50%
Fifth Third Bancorp4,923$345.4K0.00%
Verition Fund Management LLC4,460$312.9K0.00%
Headlands Technologies LLC4,322$303.2K0.03%
Capstone Investment Advisors, LLC3,799$266.5K0.00%
Gabelli Funds LLC3,600$252.5K0.00%
Principal Financial Group Inc2,855$200.3K0.00%
Bayforest Capital Ltd703$49.3K0.06%
Antipodes Partners Ltd555$38.9K0.00%
Caitong International Asset Management Co., Ltd363$25.5K0.00%
Advisory Services Network, LLC190$13.3K0.00%
Northwestern Mutual Wealth Management Co182$12.8K0.00%
SMA Capital LLC80$5.61K0.00%
Larson Financial Group LLC36$2.52K0.00%
Rossby Financial, LCC30$2.11K0.00%
Arlington Trust Co LLC28$1.96K0.00%
Zions Bancorporation, National Association14$9820.00%
Cullen/Frost Bankers, Inc.6$4210.00%
Hughes Financial Services, LLC3$2100.00%
GHP Investment Advisors, Inc.1$710.00%
Twin Peaks Wealth Advisors, LLC1$700.00%

Sold out (35)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of TARS in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
OrbiMed Advisors LLC154,400$12.6M
Squadron Capital Management LLC80,000$6.55M
EAM Investors, LLC72,922$5.97M
F/M Investments LLC39,240$3.21M
Silverarc Capital Management, LLC36,124$2.96M
Penserra Capital Management LLC29,430$2.41M
Campbell & CO Investment Adviser LLC25,364$2.08M
HRT Financial LP24,774$2.03M
Ishara Investments LP24,000$1.97M
Voloridge Investment Management, LLC23,363$1.91M
Tudor Investment Corp Et Al22,704$1.86M
Schonfeld Strategic Advisors LLC20,674$1.69M
Jane Street Group, LLC20,486$1.68M
Quest Partners LLC19,193$1.57M
Baader Bank INC12,000$982.6K
Entropy Technologies, LP9,396$769.3K
Two Sigma Advisers, LP9,100$745.1K
Jain Global LLC9,096$744.8K
FORA Capital, LLC8,877$726.8K
AlphaCore Capital LLC8,750$716.5K
Winton Group Ltd6,446$527.8K
Dynamic Technology Lab Private Ltd5,160$423.0K
Brevan Howard Capital Management LP4,458$365.0K
Rafferty Asset Management, LLC2,875$235.4K
Thoroughbred Financial Services, LLC2,725$223.0K
Mackenzie Financial Corp2,454$201.6K
Quarry LP2,400$196.5K
Amalgamated Bank1,231$101.0K
Spire Wealth Management143$11.7K
Daiwa Securities Group Inc.137$11.0K
SRS Capital Advisors, Inc.132$10.8K
Accent Capital Management, LLC85$6.96K
Signaturefd, LLC7$573
Breakwater Investment Management6$492
Turning Point Benefit Group, Inc.2$163

Not filed for Q1 2026 yet (6)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TARS in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc2,399,560$196.5M
Norges Bank117,592$9.63M
CIBC World Markets Corp2,591$212.2K
CIBC Private Wealth Group, LLC2,500$204.7K
Comerica Bank855$70.0K
Global Retirement Partners, LLC73$5.98K